Crinetics Pharmaceuticals, Inc.

CRNX · Nasdaq · SIC 2834: Pharmaceutical Preparations
166
SEC Filings

Business Summary

Business Overview We are a pharmaceutical company committed to transforming the treatment of endocrine diseases and endocrine-related tumors through science rooted in patient needs. We are focused on discovering, developing, and commercializing novel therapies, with a core expertise in targeting GPCRs with small molecules that have specifically tailored pharmacology and properties. Our lead product, PALSONIFY (paltusotine), is the first once-daily, oral treatment approved by the FDA for the trea...

Next Earnings

Q2 FY2026 — expected 2026-09-16

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionCRNXdiscussed_in_filing Cybersecurity
topic_mentionCRNXdiscussed_in_filing Trusted Computing
topic_mentionCRNXdiscussed_in_filing Blockchain & Crypto
topic_mentionCRNXdiscussed_in_filing Regulation
topic_mentionCRNXdiscussed_in_filing Healthcare & Bio
topic_mentionCRNXdiscussed_in_filing Platform & Ecosystem
topic_mentionCRNXdiscussed_in_filing Networking
topic_mentionCRNXdiscussed_in_filing Sovereign & Government
topic_mentionCRNXdiscussed_in_filing Cybersecurity
topic_mentionCRNXdiscussed_in_filing Trusted Computing
topic_mentionCRNXdiscussed_in_filing Blockchain & Crypto
topic_mentionCRNXdiscussed_in_filing Regulation
topic_mentionCRNXdiscussed_in_filing Healthcare & Bio
topic_mentionCRNXdiscussed_in_filing Platform & Ecosystem
topic_mentionCRNXdiscussed_in_filing Networking
topic_mentionCRNXdiscussed_in_filing Sovereign & Government
topic_mentionCRNXdiscussed_in_filing Cybersecurity
topic_mentionCRNXdiscussed_in_filing Trusted Computing
topic_mentionCRNXdiscussed_in_filing Blockchain & Crypto
topic_mentionCRNXdiscussed_in_filing Regulation

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-262025-12-310001658247-26-000012EDGAR82K words
2025-02-272024-12-310000950170-25-029050EDGAR—
2024-02-282023-12-310000950170-24-022108EDGAR—
2023-02-282022-12-310000950170-23-005132EDGAR—
2022-03-302021-12-310000950170-22-005050EDGAR—
2021-03-302020-12-310001564590-21-016719EDGAR—
2020-03-092019-12-310001564590-20-009365EDGAR—
2019-03-132018-12-310001564590-19-007561EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-062025-09-300001658247-25-000019EDGAR17K words
2025-08-072025-06-300001193125-25-175498EDGAR—
2025-05-082025-03-310000950170-25-066982EDGAR—
2024-11-122024-09-300000950170-24-125420EDGAR—
2024-08-082024-06-300000950170-24-093977EDGAR—
2024-05-092024-03-310000950170-24-057150EDGAR—
2023-11-072023-09-300000950170-23-060254EDGAR—
2023-08-082023-06-300000950170-23-039350EDGAR—
2023-05-092023-03-310000950170-23-019821EDGAR—
2022-11-142022-09-300000950170-22-024736EDGAR—
2022-08-122022-06-300000950170-22-017020EDGAR—
2022-05-122022-03-310000950170-22-009740EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-230001658247-26-000020EDGAR1K words
2026-03-030001658247-26-000017EDGAR—
2026-02-260001658247-26-000011EDGAR—
2026-01-260001658247-26-000003EDGAR—
2026-01-130001193125-26-011872EDGAR—
2026-01-070001193125-26-006421EDGAR—
2026-01-050001193125-26-002368EDGAR—
2025-12-170001658247-25-000022EDGAR—
2025-11-060001658247-25-000018EDGAR—
2025-09-260001658247-25-000008EDGAR—

166 total filings indexed. 136 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001658247
TickerCRNX
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: aef254923be430d85d3afc7438e7f9f2c574d8011906f2ce0e9345def7b87812
parent: 4631fdeb45527d34c540088a139e152f1f572078a08b24f5a6d4ffdbfd801d2c
content hash: 37cd22712cbb7e2949dbf28e61c5a0035f8f28162f0c2a33d9de5acef33dd611
signed: 2026-04-13T04:44:30.040Z
sources: 20 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf